CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.390
-0.020 (-4.85%)
At close: Apr 28, 2026, 4:00 PM EDT
0.390
-0.000 (-0.03%)
After-hours: Apr 28, 2026, 6:39 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $5.62 million as of April 28, 2026. Its market cap has decreased by -80.06% in one year.
Market Cap
5.62M
Enterprise Value
2.88M
1-Year Change
-80.06%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $5.62M, a decrease of -81.62%. That is a compound annual growth rate of -18.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.20M | -70.95% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.56M |
| Akari Therapeutics, | 6.56M |
| FibroBiologics | 6.45M |
| XTL Biopharmaceuticals | 6.33M |
| Purple Biotech | 6.23M |
| BioRestorative Therapies | 5.86M |
| Aptevo Therapeutics | 5.76M |
| Mustang Bio | 5.71M |